Ozempic vs. The Gym: Bank of America’s $250 Million GLP-1 Gamble For Employees
Major American companies are spending hundreds of millions of dollars to cover GLP-1 weight loss drugs for their workforce. Bank of America alone is dedicating $250 million to provide these medications to qualifying employees. But is this the best way to handle corporate health?
Top Videos
Ozempic vs. The Gym: Bank of America’s $250 Million GLP-1 Gamble For Employees
Houston weather: Heat, rain chances continue into fall season
Children involved in separate Houston road rage shootings
Homecoming mum costs on the rise
Austin ICE shooting: Video shows driver wounded
Legal insight on media banned from White House
'Chalk Talk's' Kim Davis on Texans' Bengals loss
Diesel fuel costs affecting US breweries
Tropical Weather forecast: Tropical Storm Faye, Hurricane Polo, and more
Road rage suspect charged with capital murder in death of 5-year-old
IRAN WARNS U.S. | D.C. Daily
Child killed in suspected road rage shooting
Hispanic Heritage parade held in Downtown Houston
US-Iran: Poll shows doubt for plan to end war
Flyers for fake events catfishing Houstonians
Teens cross Houston-area highway; 1 hit by vehicle
AI-generated flyers trick social media users
Man shot, killed near Houston METRO bus stop
Houston Rodeo breaks ground on new agriculture complex
Harris County tax increases included in budget
Knife pulled during Jersey Village school fight
Hispanic Heritage spotlight: Westfield Fire Chief Adrian Dillehay
Conroe considers hosting US Space Academy
Generator workshop happening this weekend
Chris Brown, Texas politicians respond to concert backlash
